Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety and pharmacokinetics of inhaled ciprofloxacin in patients with moderate to severe chronic obstructive pulmonary disease. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• inhaled ciprofloxacin (ciprofloxacin)

Snippet

Sponsor: Bayer | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED